E-drug: ADRs and cox 2 inhibitors (cont)
---------------------------------------------
The March/April 2000 edition of the MaLAM International Newsletter
provides a sceptical analysis of Pfizer and Searle�s promotion of
celecoxib in Australia.
If you have access to www then visit
http://www.camtech.net.au/malam/editions/IN0004.htm
If not then ask me to send you the text without the pictures by e-mail.
regards,
Peter
Dr Peter Mansfield
GP and consultant on marketing and appropriate therapeutics
Visiting lecturer, Universities of Adelaide, Flinders, South Australia,
Tasmania
Cardiovascular adviser, Adelaide Western Division of General Practice
Primary author, Healthy Scepticism
Director, MaLAM (Medical Lobby for Appropriate Marketing)
MaLAM aims to protect compassionate scientific health care from
marketing practices that may be detrimental to health.
peter.mansfield@flinders.edu.au
www.malam.asn.au
PO Box 172 Daw Pk SA 5041 Australia
ph/fax +61 8 8374 2245
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.